Search

Your search keyword '"Jeff Reeve"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Jeff Reeve" Remove constraint Author: "Jeff Reeve" Topic business.industry Remove constraint Topic: business.industry
70 results on '"Jeff Reeve"'

Search Results

1. Discovering novel injury features in kidney transplant biopsies associated with TCMR and donor aging

2. Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity

Catalog

Books, media, physical & digital resources

3. Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiers

4. A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection

5. Impact of Belatacept Conversion on Renal Function, Histology, and Gene Expression in Kidney Transplant Patients With Chronic Active Antibody-mediated Rejection

6. Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients

7. A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression

8. A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

9. Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System

10. Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study

11. Molecular assessment of disease states in kidney transplant biopsy samples

12. Exploring the cardiac response to injury in heart transplant biopsies

13. Molecular Microscope Determinants of Graft Survival in the INTERHEART Study

14. Clinical and Pathological Insights of Myocardial Molecular Profiling: Time to Revise ISHLT Grading System?

15. Molecular Analysis of Transbronchial and Mucosal Biopsies in Patients with CLAD

16. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients

17. Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes

18. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection

19. Molecular Assessment of Heart Transplant Biopsies

20. By Molecular Analysis, Many ISHLT Histologic Rejection Diagnoses Are Associated With Molecular Injury, Not Molecular Rejection

21. Validating the INTERHEART Classifiers for Molecular Diagnosis of Rejection in 558 New Endomyocardial Biopsies

22. Kidney Transplants With Progressing Chronic Diseases Express High Levels of Acute Kidney Injury Transcripts

23. Molecular Diagnosis of T Cell-Mediated Rejection in Human Kidney Transplant Biopsies

24. Biopsy transcriptome expression profiling: proper validation is key

25. Hyalinosis Lesions in Renal Transplant Biopsies: Time-Dependent Complexity of Interpretation

26. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence

27. Loss of Solute Carriers in T Cell‐Mediated Rejection in Mouse and Human Kidneys: An Active Epithelial Injury–Repair Response

28. A molecular classifier for predicting future graft loss in late kidney transplant biopsies

29. Improving the Diagnosis of Rejection by Molecular Phenotype of Endomyocardial Biopsies: Single Center Insights from the Interheart Study

30. Histologic and Molecular Microscope Determinants of Graft Survival in the INTERHEART Study: The Greater Importance of T Cell-mediated Rejection vs. Antibody-mediated Rejection in Graft Loss

31. Molecular Diagnosis of Rejection Phenotypes in Lung Transplant Biopsies: Initial Findings of the INTERLUNG Study

32. Molecular Diagnosis of Rejection Phenotypes in 889 Heart Transplant Biopsies: The INTERHEART Study

33. Diagnosing Rejection in Renal Transplants: A Comparison of Molecular- and Histopathology-Based Approaches

34. Molecular Correlates of Renal Function in Kidney Transplant Biopsies

35. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis

36. Association of Interleukin 23 Receptor Variants with Psoriatic Arthritis

37. Expression of B Cell and Immunoglobulin Transcripts Is a Feature of Inflammation in Late Allografts

38. The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function

39. Relationships among injury, fibrosis, and time in human kidney transplants

40. Microarray Analysis of Rejection in Human Kidney Transplants Using Pathogenesis-Based Transcript Sets

41. Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection

42. The molecular phenotypes of rejection in kidney transplant biopsies

43. Microarray Analysis of Transbronchial Biopsies in Lung Transplant Recipients Detects Molecular Changes of T-cell Mediated Inflammation

44. Common errors in the implementation and interpretation of microarray studies

45. Molecular Profiling of Endomyocardial Biopsies and Clinical Phenotype of Graft Dysfunction: Taking Rejection Diagnosis Beyond Pathological Findings

46. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM)

47. Banff fibrosis study: multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies

48. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies

49. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study

50. Molecular diagnosis of antibody-mediated rejection in human kidney transplants